Matches in SemOpenAlex for { <https://semopenalex.org/work/W4233656717> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4233656717 endingPage "405" @default.
- W4233656717 startingPage "400" @default.
- W4233656717 abstract "We investigated the effect of a candidate artificial blood substitute, Fluosol-DA (FDA), on human neutrophil function in a serum-free medium. In a 50% (vol/vol) mixture with polymorphonuclear cells (PMN), FDA had no effect on PMN viability, phagocytosis, superoxide anion generation, degranulation, or bactericidal activity. In striking contrast, the random migration and chemotaxis of PMN to both f-Met-Leu-Phe (fMLP) and activated serum were inhibited by 98% +/- 2%, 95% +/- 2%, and 88% +/- 6%, respectively. Inhibition of chemotaxis by FDA required no preincubation, was dose-dependent (50% inhibition [ID50] with a 14% vol/vol mixture with FDA), and was fully reversible by washing PMN free of FDA after one hour but not after 18 hours of incubation (32% +/- 11% inhibition of chemotaxis). FDA itself was not chemotactic and did not impair either the chemotactic activity or binding of fMLP to PMN. FDA also inhibited PMN adhesion (ID50, 9 +/- 1 vol/vol%). The inhibitory component of FDA was found to be its detergent additive, Pluronic F-68, which inhibited random migration, chemotaxis, and adhesion with ID50s of 1.4, 2.4, and 2.9 mg/mL, respectively (equivalent to FDA concentrations of 5, 9, and 11 vol/vol%, respectively). All the other components of FDA were noninhibitory. Plasma samples from humans injected with 8 mL/kg FDA and plasma samples from rabbits injected with 16 mL/kg FDA or an equivalent concentration of Pluronic F-68, when mixed with autologous PMN, also severely inhibited PMN chemotaxis. We conclude that exposure of PMN to clinically relevant concentrations of FDA inhibits PMN migration, presumably due to inhibition of adhesion. The inhibitory effect is entirely due to the detergent, Pluronic F-68. Artificial blood substitutes containing Pluronic F-68 may compromise the ability of PMN to prevent or effectively control microbial infections." @default.
- W4233656717 created "2022-05-12" @default.
- W4233656717 creator A5056261930 @default.
- W4233656717 creator A5063298929 @default.
- W4233656717 date "1984-08-01" @default.
- W4233656717 modified "2023-10-16" @default.
- W4233656717 title "Paralysis of phagocyte migration due to an artificial blood substitute" @default.
- W4233656717 doi "https://doi.org/10.1182/blood.v64.2.400.bloodjournal642400" @default.
- W4233656717 hasPublicationYear "1984" @default.
- W4233656717 type Work @default.
- W4233656717 citedByCount "1" @default.
- W4233656717 crossrefType "journal-article" @default.
- W4233656717 hasAuthorship W4233656717A5056261930 @default.
- W4233656717 hasAuthorship W4233656717A5063298929 @default.
- W4233656717 hasBestOaLocation W42336567171 @default.
- W4233656717 hasConcept C153911025 @default.
- W4233656717 hasConcept C160448771 @default.
- W4233656717 hasConcept C16685009 @default.
- W4233656717 hasConcept C170493617 @default.
- W4233656717 hasConcept C181199279 @default.
- W4233656717 hasConcept C185592680 @default.
- W4233656717 hasConcept C202751555 @default.
- W4233656717 hasConcept C203014093 @default.
- W4233656717 hasConcept C25642318 @default.
- W4233656717 hasConcept C2777983669 @default.
- W4233656717 hasConcept C2780795997 @default.
- W4233656717 hasConcept C49802076 @default.
- W4233656717 hasConcept C54166955 @default.
- W4233656717 hasConcept C55493867 @default.
- W4233656717 hasConcept C71924100 @default.
- W4233656717 hasConcept C86803240 @default.
- W4233656717 hasConcept C98274493 @default.
- W4233656717 hasConceptScore W4233656717C153911025 @default.
- W4233656717 hasConceptScore W4233656717C160448771 @default.
- W4233656717 hasConceptScore W4233656717C16685009 @default.
- W4233656717 hasConceptScore W4233656717C170493617 @default.
- W4233656717 hasConceptScore W4233656717C181199279 @default.
- W4233656717 hasConceptScore W4233656717C185592680 @default.
- W4233656717 hasConceptScore W4233656717C202751555 @default.
- W4233656717 hasConceptScore W4233656717C203014093 @default.
- W4233656717 hasConceptScore W4233656717C25642318 @default.
- W4233656717 hasConceptScore W4233656717C2777983669 @default.
- W4233656717 hasConceptScore W4233656717C2780795997 @default.
- W4233656717 hasConceptScore W4233656717C49802076 @default.
- W4233656717 hasConceptScore W4233656717C54166955 @default.
- W4233656717 hasConceptScore W4233656717C55493867 @default.
- W4233656717 hasConceptScore W4233656717C71924100 @default.
- W4233656717 hasConceptScore W4233656717C86803240 @default.
- W4233656717 hasConceptScore W4233656717C98274493 @default.
- W4233656717 hasIssue "2" @default.
- W4233656717 hasLocation W42336567171 @default.
- W4233656717 hasOpenAccess W4233656717 @default.
- W4233656717 hasPrimaryLocation W42336567171 @default.
- W4233656717 hasRelatedWork W11464624 @default.
- W4233656717 hasRelatedWork W12883621 @default.
- W4233656717 hasRelatedWork W13569708 @default.
- W4233656717 hasRelatedWork W13846801 @default.
- W4233656717 hasRelatedWork W2927342 @default.
- W4233656717 hasRelatedWork W3857660 @default.
- W4233656717 hasRelatedWork W4596591 @default.
- W4233656717 hasRelatedWork W4754996 @default.
- W4233656717 hasRelatedWork W6847777 @default.
- W4233656717 hasRelatedWork W8000352 @default.
- W4233656717 hasVolume "64" @default.
- W4233656717 isParatext "false" @default.
- W4233656717 isRetracted "false" @default.
- W4233656717 workType "article" @default.